Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb 3;6(2):e16764.
doi: 10.1371/journal.pone.0016764.

Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome

Affiliations

Interferon gamma-dependent intestinal pathology contributes to the lethality in bacterial superantigen-induced toxic shock syndrome

Ashenafi Y Tilahun et al. PLoS One. .

Abstract

Toxic shock syndrome (TSS) caused by the superantigen exotoxins of Staphylococcus aureus and Streptococcus pyogenes is characterized by robust T cell activation, profound elevation in systemic levels of multiple cytokines, including interferon-γ (IFN-γ), followed by multiple organ dysfunction and often death. As IFN-γ possesses pro- as well as anti-inflammatory properties, we delineated its role in the pathogenesis of TSS. Antibody-mediated in vivo neutralization of IFN-γ or targeted disruption of IFN-γ gene conferred significant protection from lethal TSS in HLA-DR3 transgenic mice. Following systemic high dose SEB challenge, whereas the HLA-DR3.IFN-γ(+/+) mice became sick and succumbed to TSS, HLA-DR3.IFN-γ(-/-) mice appeared healthy and were significantly protected from SEB-induced lethality. SEB-induced systemic cytokine storm was significantly blunted in HLA-DR3.IFN-γ(-/-) transgenic mice. Serum concentrations of several cytokines (IL-4, IL-10, IL-12p40 and IL-17) and chemokines (KC, rantes, eotaxin and MCP-1) were significantly lower in HLA-DR3.IFN-γ(-/-) transgenic mice. However, SEB-induced T cell expansion in the spleens was unaffected and expansion of SEB-reactive TCR Vβ8(+) CD4(+) and CD8(+) T cells was even more pronounced in HLA-DR3.IFN-γ(-/-) transgenic mice when compared to HLA-DR3.IFN-γ(+/+) mice. A systematic histopathological examination of several vital organs revealed that both HLA-DR3.IFN-γ(+/+) and HLA-DR3.IFN-γ(-/-) transgenic mice displayed comparable severe inflammatory changes in lungs, and liver during TSS. Remarkably, whereas the small intestines from HLA-DR3.IFN-γ(+/+) transgenic mice displayed significant pathological changes during TSS, the architecture of small intestines in HLA-DR3.IFN-γ(-/-) transgenic mice was preserved. In concordance with these histopathological changes, the gut permeability to macromolecules was dramatically increased in HLA-DR3.IFN-γ(+/+) but not HLA-DR3.IFN-γ(-/-) mice during TSS. Overall, IFN-γ seemed to play a lethal role in the immunopathogenesis of TSS by inflicting fatal small bowel pathology. Our study thus identifies the important role for IFN-γ in TSS.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. In vivo antibody mediated neutralization of IFN-γ protects from lethal SEB-induced TSS.
Age-matched HLA-DR3 transgenic mice were challenged with SEB (50 µg) immediately followed by indicated amounts of monoclonal rat anti-mouse IFN-γ or isotype control. Mice were closely monitored for symptoms of TSS.
Figure 2
Figure 2. Effect of antibody mediated neutralization of IFN-γ on SEB-induced cytokine and chemokine responses in vivo.
Age-matched HLA-DR3 transgenic mice were challenged with SEB (5 µg) immediately followed by 100 µg of goat anti-mouse IFN-γ or control goat antibodies. Mice were bled 3 hrs later and serum cytokine levels were determined using a multiplex suspension array system (Bio-Plex, Bio-Rad). Each bar represents the mean±SE of 4–6 mice.
Figure 3
Figure 3. Effect of antibody mediated neutralization of IFN-γ on SEB-induced splenic T cell expansion and thymocyte deletion.
Age-matched HLA-DR3 transgenic mice were challenged with SEB (5 µg) immediately followed by 100 µg of goat anti-mouse IFN-γ or control goat antibodies. Mice were killed 3 days later and distribution of different T cell subsets in the spleen (A and B) and thymus (C and D) was determined by flow cytometry. Each bar represents the mean±SE of 4–6 mice.
Figure 4
Figure 4. Effect of IFN-γ deficiency on SEB-induced TSS.
Age-matched HLA-DR3.IFN-γ+/+ and HLA-DR3.IFN-γ−/− transgenic mice were challenged with SEB (50 µg) and monitored closely. Data from 6–13 mice in each group.
Figure 5
Figure 5. Effect of IFN-γ deficiency on SEB-induced cytokine responses in vivo.
Age-matched HLA-DR3.IFN-γ+/+ and HLA-DR3.IFN-γ−/− transgenic mice were challenged with SEB (10 µg). Mice were bled at 3 hrs and serum cytokine levels were determined using a multiplex suspension array system (Bio-Plex, Bio-Rad).
Figure 6
Figure 6. Effect of IFN-γ deficiency on SEB-induced chemokine responses in vivo.
Age-matched HLA-DR3.IFN-γ+/+ and HLA-DR3.IFN-γ−/− transgenic mice were challenged with SEB (10 µg). Mice were bled at 3 hrs and serum chemokine levels were determined using a multiplex suspension array system (Bio-Plex, Bio-Rad).
Figure 7
Figure 7. Effect of IFN-γ deficiency on SEB-induced splenic T cell expansion and thymocyte deletion.
Age-matched HLA-DR3.IFN-γ+/+ and HLA-DR3.IFN-γ−/− transgenic mice were challenged with SEB (10 µg). Mice were killed 3 days later and distribution of different T cell subsets in the spleen (A and B) and thymus (C and D) was determined by flow cytometry. Each bar represents the mean±SE of 4–6 mice.
Figure 8
Figure 8. Effect of IFN-γ deficiency on SEB-induced pulmonary immunopathology.
Age-matched HLA-DR3.IFN-γ+/+ (A and C) and HLA-DR3.IFN-γ−/− (B and D) transgenic mice were left untreated (A and B) or challenged with SEB (50 µg, C and D). Mice were killed 48 hrs later, lungs were collected in buffered formalin and processed for H&E. The bar corresponds to 100 µM.
Figure 9
Figure 9. Effect of IFN-γ deficiency on SEB-induced hepatic immunopathology.
Age-matched HLA-DR3.IFN-γ+/+ (A to D) and HLA-DR3.IFN-γ−/− (E and H) transgenic mice were challenged with PBS (A, B and E, F) or challenged with SEB (50 µg) (C, D and G, H). Mice were killed 48 hrs later, livers were collected in buffered formalin and processed for H&E. The bar corresponds to 100 µM.
Figure 10
Figure 10. Effect of IFN-γ deficiency on SEB-induced intestinal immunopathology.
Age-matched HLA-DR3.IFN-γ+/+ (D, E and F) and HLA-DR3.IFN-γ−/− (G, H and I) transgenic mice were challenged with SEB (50 µg). Mice were killed 48 hrs later, intestinal segments were collected in buffered formalin and processed for H&E. Panels A, B and C – sections from naïve HLA-DR3.IFN-γ+/+ mice shown for comparison. The bar corresponds to 100 µM.
Figure 11
Figure 11. Effect of IFN-γ deficiency on SEB-induced duodenal immunopathology.
Age-matched HLA-DR3.IFN-γ+/+ (A, C and E) and HLA-DR3.IFN-γ−/− (B, D and F) transgenic mice were challenged with SEB (50 µg). Mice were killed at 24, 48 and 72 hrs, duodenal segments were collected in buffered formalin and processed for H&E. The bar corresponds to 100 µM.
Figure 12
Figure 12. Effect of IFN-γ deficiency on SEB-induced alteration in gut permeability.
Age-matched HLA-DR3.IFN-γ+/+ and HLA-DR3.IFN-γ−/− transgenic mice were challenged with SEB (50 µg). Mice were gavaged with FITC-dextran as indicated in methods. Three hours after gavage, mice were killed, sera collected and the fluorescence in the sera were determined at 490 nm excitation and 525 nm emission.

Similar articles

Cited by

References

    1. Yok-Al Que, Moreill P. Staphylococcus aureus (Including Staphylococcal Toxic Shock). In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's principles and practice of infectious diseases 9ed. Philadelphia: Churchill Livingstone, Elsevier; 2009.
    1. Lappin E, Ferguson AJ. Gram-positive toxic shock syndromes. Lancet Infect Dis. 2009;9:281–290. - PubMed
    1. Aldape MJ, Bryant AE, Stevens DL. Clostridium sordellii Infection: Epidemiology, Clinical Findings, and Current Perspectives on Diagnosis and Treatment. Clinical Infectious Diseases. 2006;43:1436–1446. - PubMed
    1. Murray RJ. Recognition and management of Staphylococcus aureus toxin-mediated disease. Internal Medicine Journal. 2005;35:S106–S119. - PubMed
    1. Todd JK. Staphylococcal Toxin Syndromes. Annual Review of Medicine. 1985;36:337–347. - PubMed

Publication types

MeSH terms